Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Rader

Showing results (51-60 of 821) with videos related to

Pageof 83
Sort By:
Circulation|March 1, 2006
Emerging therapies targeting high-density lipoprotein metabolism and reverse cholesterol transportDanielle Duffy, Daniel J Rader
Annual Review of Medicine|February 8, 2018
New Therapeutic Approaches for Familial HypercholesterolemiaEzim Ajufo, Daniel J Rader
Nature Medicine|October 6, 2007
'Multipurpose oxidase' in atherogenesisDaniel J Rader, Harry Ischiropoulos
Gastroenterology|May 15, 2007
Obesity and atherogenic dyslipidemiaVaneeta Bamba, Daniel J Rader
Circulation|June 1, 2006
Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?Marina Cuchel, Daniel J Rader
Nature|February 22, 2008
Translating molecular discoveries into new therapies for atherosclerosisDaniel J Rader, Alan Daugherty
Circulation Research|May 24, 2014
Apolipoprotein A-I and cholesterol efflux: the good, the bad, and the modifiedAli Javaheri, Daniel J Rader
Current Opinion in Lipidology|October 17, 2012
Effect of interleukin 1β inhibition in cardiovascular diseaseArman Qamar, Daniel J Rader
Current Cardiovascular Risk Reports|August 20, 2011
Clinical Implications of Lipid Genetics for Cardiovascular DiseaseAlanna Strong, Daniel J Rader
Nature Reviews. Cardiology|June 3, 2009
Update on strategies to increase HDL quantity and functionDanielle Duffy, Daniel J Rader
Pageof 83

Showing results (51-60 of 821) with videos related to

Sort By:
Pageof 83
Circulation|March 1, 2006
Emerging therapies targeting high-density lipoprotein metabolism and reverse cholesterol transportDanielle Duffy, Daniel J Rader
Annual Review of Medicine|February 8, 2018
New Therapeutic Approaches for Familial HypercholesterolemiaEzim Ajufo, Daniel J Rader
Nature Medicine|October 6, 2007
'Multipurpose oxidase' in atherogenesisDaniel J Rader, Harry Ischiropoulos
Gastroenterology|May 15, 2007
Obesity and atherogenic dyslipidemiaVaneeta Bamba, Daniel J Rader
Circulation|June 1, 2006
Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?Marina Cuchel, Daniel J Rader
Nature|February 22, 2008
Translating molecular discoveries into new therapies for atherosclerosisDaniel J Rader, Alan Daugherty
Circulation Research|May 24, 2014
Apolipoprotein A-I and cholesterol efflux: the good, the bad, and the modifiedAli Javaheri, Daniel J Rader
Current Opinion in Lipidology|October 17, 2012
Effect of interleukin 1β inhibition in cardiovascular diseaseArman Qamar, Daniel J Rader
Current Cardiovascular Risk Reports|August 20, 2011
Clinical Implications of Lipid Genetics for Cardiovascular DiseaseAlanna Strong, Daniel J Rader
Nature Reviews. Cardiology|June 3, 2009
Update on strategies to increase HDL quantity and functionDanielle Duffy, Daniel J Rader
Pageof 83